سعر اديباكت 200 مجم 10 اقراص 2026

Rifaximin 200 mg film-coated tablets (Idibact; International Drug Industries > Novell Pharma, Egypt); pack of 10 tablets.

• Travelers' diarrhoea caused by noninvasive strains of Escherichia coli in adults and children 12 years and older; not for diarrhoea complicated by fever or blood in stool or due to other pathogens.Population: Adults and children >=12 yearsDailyMed (U.S. National Library of Medicine)

• Travelers' diarrhoea trials: the only adverse reaction at >=2% and more often than placebo was headache (10% vs 9%).International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Hypersensitivity to rifaximin, any rifamycin antimicrobial agent or any component (reactions have included exfoliative dermatitis, angioneurotic oedema and anaphylaxis).International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Not effective in travelers' diarrhoea complicated by fever and/or blood in stool or caused by pathogens other than E. coli (e.g. Campylobacter jejuni; not proven for Shigella/Salmonella); discontinue if symptoms worsen or persist beyond 24-48 hours.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Clostridioides difficile-associated diarrhoea has been reported and may range from mild diarrhoea to fatal colitis.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Prescribing without a proven or strongly suspected bacterial infection increases the risk of drug-resistant bacteria.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• P-glycoprotein inhibitors (e.g. cyclosporine)Cyclosporine significantly increased systemic rifaximin exposure; use caution, especially in hepatic impairment.DailyMed (U.S. National Library of Medicine)
• WarfarinINR changes reported; monitor INR and prothrombin time and adjust warfarin as needed.DailyMed (U.S. National Library of Medicine)

• No human pregnancy data; teratogenic effects (ocular, oral/maxillofacial, cardiac and lumbar spine malformations) were observed in rats and rabbits.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• No information on presence in human milk or effects on the breastfed infant or milk production; weigh benefits against maternal need.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Rifaximin: Binds the beta-subunit of bacterial DNA-dependent RNA polymerase, inhibiting bacterial RNA synthesis.